These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. The induction of immunoblastic T cell sarcomas by virus-transformed prothymocytes. Reinisch CL, Kurtz SE, Morris EA, Lampert A. Am J Pathol; 1980 Nov; 101(2):265-82. PubMed ID: 6254363 [Abstract] [Full Text] [Related]
6. A cloned lymphoid Thy1+ tumor line derived from murine yolk sac cells maintained in long-term cell culture in the absence of a thymic microenvironment expresses an unusual cell surface phenotype. Liu CP, Globerson A, Auerbach R. Thymus; 1993 Jun; 21(4):221-33. PubMed ID: 7904386 [Abstract] [Full Text] [Related]
8. Cell-mediated cytotoxic responses induced in vivo and in vitro by a metastatic murine tumor. Wiltrout RH, Frost P. J Immunol; 1980 May; 124(5):2254-63. PubMed ID: 7365255 [No Abstract] [Full Text] [Related]
10. Chemosensitization of human prostate carcinoma cell lines to anti-fas-mediated cytotoxicity and apoptosis. Uslu R, Borsellino N, Frost P, Gárban H, Ng CP, Mizutani Y, Belldegrun A, Bonavida B. Clin Cancer Res; 1997 Jun; 3(6):963-72. PubMed ID: 9815772 [Abstract] [Full Text] [Related]
11. Local delivery of recombinant vaccinia virus expressing secondary lymphoid chemokine (SLC) results in a CD4 T-cell dependent antitumor response. Flanagan K, Glover RT, Hörig H, Yang W, Kaufman HL. Vaccine; 2004 Jul 29; 22(21-22):2894-903. PubMed ID: 15246626 [Abstract] [Full Text] [Related]
14. Induction of Ly-49 on an interspecies hybridoma between differentiation stage specific murine T cells and a rat T lymphoma. Nagasawa R, Maruyama N, Kubo S, Yumura W, Mitarai T, Isoda K, Kanagawa O. Cell Immunol; 1994 Jun 29; 156(1):180-90. PubMed ID: 8200034 [Abstract] [Full Text] [Related]
15. [LAK sensitivity of human pancreas carcinoma cell lines]. Sugiura H. Hokkaido Igaku Zasshi; 1993 Nov 29; 68(6):921-34. PubMed ID: 7906667 [Abstract] [Full Text] [Related]
16. In vitro transformation of murine pro-B and pre-B cells by v-mpl, a truncated form of a cytokine receptor. Fichelson S, Vigon I, Dusanter I, Charon M, Velu T, Baillou C, Gisselbrecht S, Lemoine FM. J Immunol; 1995 Feb 15; 154(4):1577-86. PubMed ID: 7836743 [Abstract] [Full Text] [Related]
17. Fas antigen is the major target molecule for CD4+ T cell-mediated cytotoxicity. Stalder T, Hahn S, Erb P. J Immunol; 1994 Feb 01; 152(3):1127-33. PubMed ID: 7507960 [Abstract] [Full Text] [Related]
18. BALB/c mice have more CD4+CD25+ T regulatory cells and show greater susceptibility to suppression of their CD4+CD25- responder T cells than C57BL/6 mice. Chen X, Oppenheim JJ, Howard OM. J Leukoc Biol; 2005 Jul 01; 78(1):114-21. PubMed ID: 15845645 [Abstract] [Full Text] [Related]
19. Flow-microfluorometric monitoring of oligoclonal CD8+ T cell responses to an immunodominant Moloney leukemia virus-encoded epitope in vivo. Brawand P, Biasi G, Horvath C, Cerottini JC, MacDonald HR. J Immunol; 1998 Feb 15; 160(4):1659-65. PubMed ID: 9469422 [Abstract] [Full Text] [Related]